The epidermis forms a vital barrier composed of stratified keratinocytes and their differentiated products. One of these products, keratin K10, is critical to epidermal integrity, because mutations in k10 lead to abnormal blistering. For the normal expression of k10, differentiation-associated transcription factors C/EBP␣, C/EBP␤, and AP-2 are well positioned to play an important role. Here, regulation of the k10 gene is examined in keratinocytes in the skin of normal mice and in transgenic mice carrying targeted deletions of c/ebp␤ and ap-2␣. In cultured cells, C/EBP␣ and C/EBP␤ are each capable of activating the k10 promoter via three binding sites, identified by site-directed mutagenesis. In a given epidermal cell in vivo, however, the selection of C/EBP␣ versus C/EBP␤ for k10 regulation is determined via a third transcription factor, AP-2. This novel regulatory scheme involves: (1) unique gradients of expression for each transcription factor, i.e., C/EBP␤ and AP-2 most abundant in the lower epidermis, C/EBP␣ in the upper; (2) C/EBP-binding sites in the ap-2␣ gene promoter, through which C/EBP␤ stimulates ap-2␣; and (3) AP-2 binding sites in the c/ebp␣ promoter, through which AP-2 represses c/ebp␣. Promoter-analysis and gene-expression data presented herein support a regulatory model in which C/EBP␤ activates and maintains AP-2 expression in basal keratinocytes, whereas AP-2 represses C/EBP␣ in those cells. In response to differentiation signals, loss of AP-2 expression leads to derepression of the c/ebp␣ promoter and activation of k10 as cells migrate upward.
INTRODUCTION
The skin is the largest organ in the body and provides a vital barrier against fluid loss, chemical and infectious agents, and UV light (Goldsmith, 1991) . This protection is provided by the epidermis, a stratified tissue composed of progenitor cells in the basal layer and differentiated keratinocytes in the suprabasal layers. The keratinocytes produce differentiation-specific proteins, including keratins, involucrin, and loricrin (Eckert et al., 1997; Fuchs, 1990) , that ultimately become cross-linked during cornification, a specialized form of apoptosis (Haake and Polakowska, 1993) . Keratin K10 is expressed early during the differentiation of keratinocytes and is essential for epidermal integrity. Loss of normal k10 expression, through dominantnegative mutations in the heritable disorder epidermolytic hyperkeratosis, leads to epidermal disruption and blistering (Cheng et al., 1992; Rothnagel et al., 1992; Syder et al., 1994) .
Mechanisms that control k10 expression are poorly understood. In the basal epidermal layer, k10 transcription is suppressed and becomes activated upon entering the suprabasal compartment (Roop et al., 1988) . We are interested in factors that regulate k10 expression. Because of its abundance in the skin and restriction to the basal layer, we considered the transcription factor AP-2 1 as one such factor (Byrne et al., 1994; Leask et al., 1991; Mitchell et al., 1991) . AP-2 (also called AP-2␣) is a member of a family that now includes AP-2␤ (Moser et al., 1995) and AP-2␥ (OuladAbdelghani et al., 1996) ; these proteins dimerize via a helix-span-helix domain (Williams and Tjian, 1991) and bind to the consensus sequence 5Ј-GCCN 3(4) GGC-3Ј in DNA (Mitchell et al., 1987) . One or more proteins of the AP-2 family are important for the transcriptional regulation of K14, a keratin expressed specifically in the basal epidermal layer (Byrne et al., 1994) .
Transcription factors of the C/EBP (CCAAT-enhancer binding protein) family are also candidates for regulation of k10 transcription, because of their links to cellular differentiation (see below). C/EBPs are members of the leucine zipper or "bZIP" family of transcription factors (Haas et al., 1995; Lamb and McKnight, 1991; Vinson et al., 1993) , recognized early on for their involvement in cellular differentiation (McKnight, 1992) . C/EBPs bind to degenerate nucleotide sequence sites consisting of a consensus motif A /GTTNNG C /TAA C /T (McKnight, 1992; Osada et al., 1996; Ryden and Beemon, 1989; Ubeda et al., 1996) ; the pseudopalindromic bases (in italic) separated by four intervening basepairs are invariable. A role for C/EBPs in cellular differentiation has been established in adipocytes in which differentiation is accompanied by unique temporal changes in the levels of individual C/EBP members. Upregulation of C/EBP␦ and C/EBP␤ precedes expression of C/EBP␣ (Cao et al., 1991; MacDougald and Lane, 1995; Yeh et al., 1995) and of fat-specific genes (Friedman et al., 1989) . Direct transgenic overexpression of C/EBP␣ (Freytag et al., 1994; Lin and Lane, 1994) or of C/EBP␤ (Yeh et al., 1995) accelerates the differentiation of adipoblasts into adipocytes. These observations suggest that expression of C/EBP␤ initially, and C/EBP␣ at a later time, is a prerequisite for correct expression of the differentiation-specific genes.
Both C/EBPs and AP-2 display broad regulatory potential, through the existence of multiple isoforms and autoregulatory loops. Dominant-negative isoforms of the C/EBPs (Descombes and Schibler, 1991; Lin et al., 1993; Ossipow et al., 1993; Ron and Habener, 1992) or of AP-2 (Meier et al., 1995) heterodimerize with other isoforms in the same class, thus counteracting stimulatory effects. Autoregulation occurs because the promoters for c/ebp␣ (Christy et al., 1991; Lin et al., 1993) , c/ebp␤ (Chang et al., 1990) , and chop (Fawcett et al., 1996; Sylvester et al., 1994) each contain C/EBP-binding motifs that should be available for interactions with both stimulatory and inhibitory C/EBP isoforms. The notion of counterregulation among C/EBP family genes, at the level of their individual promoters, was recently extended by the observation of a system of crosstalk between AP-2 and C/EBPs. CUP (C/EBP␣ undifferentiated protein), a repressor of the C/EBP␣ promoter in preadipocytes (Tang et al., 1997) which disappears as the cells differentiate, is identical to AP-2 (Jiang et al., 1998) .
C/EBPs have only recently been examined in the epidermis (Maytin and Habener, 1998; Oh and Smart, 1998; Swart et al., 1997) . Earlier, we examined the expression of C/EBPs in keratinocytes of the mouse and found that C/EBP␤ and CHOP are expressed early, whereas C/EBP␣ is expressed late during keratinocyte differentiation in vitro (Maytin and Habener, 1998) . C/EBPs are expressed in the skin in a spatially organized manner that corresponds to the timing of expression seen in cultured keratinocytes in vitro, i.e., C/EBP␤ and CHOP appear first in the lower undifferentiated epidermis, followed later by C/EBP␣ in the upper differentiated epidermis (Maytin and Habener, 1998) . These findings imply that C/EBPs may exert functions in epidermal differentiation.
Here, the functions of C/EBPs in skin development and differentiation are examined more directly, emphasizing their role in k10 regulation. A segment of the mouse k10 promoter was used for transactivation and mutagenesis work in BALB/MK cells, a cell culture model of epidermal differentiation. Changes in k10 expression were found to be mediated via three C/EBP binding sites within the k10 promoter. Gene expression was examined in mice with a targeted disruption of the c/ebp␤ gene (cebp␤ null). The c/ebp␤ null mice displayed a marked ectopic increase of C/EBP␣ and K10 expression in the basal epidermis. Based on the known suppression of C/EBP␣ by AP-2 in adipocytes, we hypothesized that increase of C/EBP␣ in the skin of c/ebp␤ null mice might represent a release of the c/ebp␣ gene from transcriptional repression and that the repressor might be AP-2. Experiments in c/ebp␤ null mice showing loss of AP-2 expression, and other experiments showing that ap-2␣ null mice reproduce the skin phenotype of the c/ebp␤ null mice, support this hypothesis. Overall, the data suggest a model of regulation in which C/EBP␤ activates or maintains AP-2 expression, and AP-2 represses C/EBP␣, in undifferentiated keratinocytes. In response to differentiation signals, a loss of AP-2 expression leads to derepression of the C/EBP␣ promoter and contributes to activation of the k10 gene. This novel system of crosstalk between C/EBPs and AP-2 appears to contribute to the regulation of the differentiation-specific gene k10 in the mammalian epidermis.
MATERIALS AND METHODS

Preparation of Skin Specimens from Mice Nullizygous for c/ebp␤ and ap-2
Mice in which the bZIP region of the c/ebp␤ gene has been deleted (Screpanti et al., 1995) were a gift from Dr. Valeria Poli. These mice were backcrossed into an FVB/n background (Charles River, Wilmington, MA), and the line was maintained as heterozygous breeding pairs. ap-2␣ null mice, lacking a genomic segment containing exon 5 of the ap-2␣ gene (Schorle et al., 1996) , were also used. Because ap-2␣ null mice die perinatally, embryos from matings of heterozygotes were harvested shortly before birth (e17.5 to e18.5). The genotype of each individual was determined by PCR of tail DNA or yolk-sack DNA, for c/ebp␤ or ap-2␣, respectively.
For histological studies with c/ebp␤ knockout mice, pieces of skin from pairs of adult mice (c/ebp␤ ϩ/Ϫ and c/ebp␤ Ϫ/Ϫ, matched for age and sex) were embedded side by side in OCT freezing compound (Miles, Inc., Elkhart, IN) along with some extraneous tissue as an orientation marker. Frozen blocks were then cut into 5-m sections and stained as described under "Immunocytochemistry." For ap-2␣ studies, wild-type or ap-2␣ ϩ/Ϫ embryos were embedded side by side with ap-2␣ homozygous null embryos from the same litter. In this approach, paired tissue samples were exposed to identical conditions at every step in the processing for immunochemical analyses.
Cell Culture and Differentiation Protocol
BALB/MK cells (Weissman and Aaronson, 1983) were grown in EMEM containing low calcium (0.07 mM; Biofluids, Inc., Rockville, MD) to which 5 ng/ml EGF (Collaborative Research, Bedford, MA) and 10% Chelex-treated serum (Marcelo et al., 1978) were added. For calcium step-up experiments, EMEM supplemented with calcium to 0.12 mM (Yuspa and Dlugosz, 1991) was added to confluent cells, and this "high-calcium" medium was changed daily for the duration of the experiment to minimize effects from nutrient depletion.
Cell Transfection and Luciferase Assays
Eukaryotic expression plasmids containing the C/EBP␣, C/EBP␤, and CHOP coding sequences in pCDNA1 (InVitrogen) have been described (Ron and Habener, 1992) . These plasmids, along with luciferase reporter constructs (see "Cloning," below), were transfected into subconfluent BALB/MK cells using a standard calciumphosphate precipitate (Ausbel et al., 1992) or using Lipofectamine (Gibco BRL, 6 l per 60-mm dish, 5 h exposure). At 48 h after transfection, cells were rinsed with cold PBS, lysed in glycylglycine buffer with 0.1% Triton X, and assayed for luciferase activity in an AutoLumat LB 953 luminometer (Berthold Analytical Instruments, Nashua, NH) as described (Brasier et al., 1989) .
Cloning and Analysis of the Mouse k10 and ap-2␣ Promoters
A fragment of the mouse K10 gene promoter was obtained by utilizing a highly conserved sequence of nucleotides at Ϫ245 bp, apparent on cross-species examination of bovine and human K10 genes. A 19-base oligonucleotide corresponding to this conserved region was used as the 5Ј primer for PCR amplification of mouse genomic DNA from NIH 3T3 cells; the matched 3Ј primer corresponded to the known coding sequence of k10 at ϩ185 bp. The resulting 430-bp PCR product, containing 245 bp of promoter and 185 bp of k10 coding sequence, was ligated into plasmid pCRII (TA cloning kit; InVitrogen, San Diego, CA) to create the construct K10-pCRII. To obtain a fragment containing only the promoter, two PCR primers were designed to anneal at positions Ϫ245 bp and ϩ1 bp adding extra bases to create restriction sites as follows: 5Ј-KpnI primer, CGG GGG TAC CCA TTT TCA ATT TC; 3Ј-BglII primer, GAA GAT CTG GTG GTG TAG TGT AGC CC. Using these two primers and the K10-pCRII construct as templates, an ϳ250-bp fragment was obtained by PCR and cloned into the KpnI/BglII sites of the pGL2-Basic vector (Promega, Madison, WI) and thence into the SmaI-HindIII site of SKLuc to place the wild-type k10 promoter directly upstream of the luciferase gene. This new construct was named K10-Luc. The orientation and integrity of all inserts were confirmed by DNA sequencing. To produce the mutants described in Figs. 4C-4E, site-directed mutagenesis was performed using the QuickChange kit from Stratagene. The sequence of mutations introduced at Sites A, B, and C in the k10 promoter was identical to that of oligonucleotides Mut A, Mut B, and Mut C (see Fig. 3C and "EMSA," below).
A region of the mouse ap-2␣ gene containing C/EBP-binding motifs at Ϫ710 and Ϫ760 bp relative to the ATG codon in exon 1a (GenBank No. U17289) was synthesized as an 87-bp doublestranded oligonucleotide with NotI and BamHI ends, then ligated into an SKLuc-based reporter containing a minimal promoter (ϩ1 to Ϫ86 bp of k10). This construct was named pWtAP2Luc. A similar construct, pMutAP2Luc, harbored mutations in both C/EBP-binding motifs (see Fig. 6 for sequence).
DNase I Footprint Analysis of the k10 Promoter
To create a probe suitable for analysis of site-specific binding of proteins to DNA, the sense and antisense strands of the dsDNA probe were individually labeled using [␥- 32 P]ATP and T4 polynucleotide kinase to end-label the plasmid K10-pCRII that had been cleaved at a restriction site adjacent to the 5Ј end of the K10 insert. Subsequently, the insert was released by restriction enzyme cleavage at the unlabeled end. A truncated form of C/EBP␤ called C/EBP␤-LIP, translated from an internal methionine and containing the bZIP binding domain (Poli et al., 1990) , was used for footprinting. The C/EBP␤-LIP protein was produced as a histidinetagged fusion protein in pRSET-A (InVitrogen). After transformation of Escherichia coli strain BL21(DE3)pLysS and induction with IPTG (Studier et al., 1990) , cells were lysed and the supernatant was applied over a nickel-NTA resin column (Qiagen, Inc., Chatsworth, CA) and the protein eluted in a pH step gradient according to instructions from the manufacturer. The DNase I protection assay was performed by incubating the His-tagged C/EBP␤ with 50,000 cpm of 32 P-labeled K10 probe at 4°C for 1 h prior to digestion with DNase I, essentially as described (Galas and Schmidt, 1978) .
Electrophoretic Mobility Shift Assays (EMSA)
Double-stranded DNA probes for EMSA experiments were produced by designing matched sense and antisense oligonucleotides that produced BamHI/BglII 4-bp overhangs that could be filled in with E. coli polymerase Klenow fragment and [ 32 P]dATP. Oligonucleotides were synthesized in the MGH Biopolymer Facility and purified by electrophoresis on urea-acrylamide gels. Probe sequences are given below. Sense strands are shown, with uppercase letters denoting keratin K10 sequences and lowercase letters unrelated sequences, as they would appear after the Klenow fill-in reaction. For Fig. 3C , wild-type probes (26 bp): Site A, gatcc TAA TTT ATG CAA TCA Tagatc; Site B, gatcc GTT ATT ACT GAA GAT Aagatc; Site C, gatcc AAA ACC ATG CAA GTA Aagatc. For  Fig. 3C , mutant probes (26 bp) were identical to the wild-type probes except for the basepair substitutions underlined, as follows: Mut A, gatcc TAA TTT ATG ATA TCA Tagatc; Mut B, gatcc GTG ATC ACT GAA GAT Aagatc; Mut C, gatcc AAA AGG ATG CCC GTA Aagatc. (For Fig. 4C , the same mutant bases underlined above in Mut A, Mut B, or Mut C were introduced into the wild-type K10 promoter in various combinations by site-directed mutagenesis.) In Fig. 3C and 3D, the "Standard" probe was a high-affinity C/EBP site from the angiotensinogen gene, also known as M6 (Brasier et al., 1990) : gatc CAC AGT TGT GAT TTC ACA ACC TGA CCA Gagatc. For Fig. 3D , the K10 probe was 44 bp, consisting of native k10 sequence encompassing Sites A and B: attaCT GAA GAT AAT TTA TGC AAT CAT AAG CCA AAG ATG Ctatg.
Gel-shift assays (EMSA) were performed as described (Vallejo et al., 1992) . Briefly, 20-l reaction mixtures containing 1 ml of cell extract, 4 ml of albumin (10 mg/ml), 1 ml of poly(dIdC) (1 mg/ml), and 1 ml of 32 P-labeled dsDNA probe (20,000 cpm) were prepared at a 50 mM final salt concentration and allowed to equilibrate for 20 min at 25°C. Complexes were separated on 5% Tris/borate acrylamide gels, and the dried gel was exposed to Kodak X-Omat AR film overnight.
Immunocytochemistry
Mouse skin was frozen in OCT compound (Miles, Inc.), cut into 5-m sections, and permeabilized in methanol prior to staining. For the immunostaining of cells, BALB/MK cells were grown in fourwell plastic chamber slides (Nunc, Inc., Naperville, IL), fixed 5 min in 1% paraformaldehyde, and permeabilized in methanol followed by 0.1% Triton X-100 to promote access to nuclei (Collier and Schlesinger, 1986) . For paraffin-embedded skin, 5-m sections were deparaffinized by successive immersion in xylene, graded alcohols, and saline. All specimens were blocked in 3% normal donkey serum, incubated 12-18 h with primary antisera at 4°C, rinsed in saline, and incubated 4 h at room temperature with the secondary antibody. Slides were mounted in fluorescence mounting medium (Kirkegaard & Perry Laboratories, Gaithersburg, MD) and viewed under a Nikon Optiphot-2 microscope with epifluorescence attachments. For most experiments, rabbit polyclonal antisera were used as follows (dilution, commercial source): C/EBP␣, C/EBP␤, gadd153/CHOP (1:50; Santa Cruz Biotechnology, Santa Cruz, CA), AP-2 (1:500, Santa Cruz, sc-184), and keratin K10 and keratin K14 (1:500 and 1:2000, Berkeley Antibody Co., Berkeley, CA). Goat polyclonal antisera against AP-2␣ (1:100, Santa Cruz, sc-6312) or a mouse monoclonal antibody against keratin K10 (1:10, Sigma clone 8.6) were used in Fig. 1 only. The secondary antibody for most experiments was Cy3-conjugated donkey anti-rabbit IgG (1:1500). For double staining, Cy2-conjugated donkey anti-goat or antimouse IgG were used (Jackson ImmunoResearch, West Grove, PA). Antiserum sc-184 against AP-2 protein is not entirely specific for AP-2␣. On Western blots loaded with roughly equimolar amounts of recombinant, 35 S-labeled AP-2␣, AP-2␤, or AP-2.2 (AP-2␥), the sc-184 antibody recognizes all three proteins, although its affinity for AP-2␣ is severalfold higher than for AP-2␤ or AP-2␥ (P. J. Mitchell, data not shown).
Images were captured with a digital CCD camera (Optronics Model TEC-470 camera) attached to a Macintosh 7100 PowerPC computer with RasterOps framegrabber, running IPLab Spectrum software (Signal Analytics Corp., Vienna, VA). Integration of signal intensities, background subtraction, and normalization were performed as described (Maytin and Habener, 1998) .
Of particular note, the immunofluorescent staining patterns obtained with C/EBP-specific antisera used here were previously shown to accurately reflect the relative distribution of each C/EBP protein within cells, both for keratinocytes in vitro and for the epidermis in vivo, using Western blotting techniques (Maytin and Habener, 1998) .
RT-PCR and Southern Analysis
Equal amounts of total RNA (5 g), prepared from BALB/MK cells or from newborn mouse skin (guanidinium/phenol reagent, TelTest "B", Inc., Friendswood, TX) were reverse-transcribed using 1 l oligo(dT) primers and the Superscript II kit (Gibco BRL), following the manufacturer's instructions. As a negative control, reverse transcriptase was omitted from the reaction (data not shown). Aliquots of cDNA were then analyzed by PCR, using primers to amplify a 220-bp region at the 3Ј end of the K10 mRNA. This region corresponded to a K10 cDNA insert in pGEM-3 (gift from Dr. Dennis Roop, Baylor College of Medicine, Houston, TX) that could be employed as a positive control for PCR. As a control, each cDNA sample was amplified using primers to mouse ␤-actin (Clontech, Palo Alto, CA). Southern blots were probed, after transfer of RT-PCR products to nitrocellulose membranes, using a mixture of 32 P-end-labeled oligonucleotides complementary to the internal region of the amplified K10 product.
Western Analysis
Western immunoblotting was performed using polyclonal K10 antisera at a 1:5000 dilution (gift from Dr. Stuart Yuspa, NCI, Bethesda; also available from Berkeley Antibody Co.) as previously described (Maytin and Habener, 1998) . Films were quantified with a 2-D laser scanning densitometer (Molecular Dynamics, Sunnyvale, CA).
RESULTS
AP-2, C/EBPs, and Keratin K10 Are Differentially Expressed in Stratifying Epidermis
The epidermis consists of morphologically distinct cell layers, notable for their unique patterns of expression of K10 and of the transcription factors AP-2, C/EBP␣, and C/EBP␤ (Fig. 1 ). Architecturally, a single proliferative layer of basal cells is surmounted by differentiating suprabasal cells, which eventually undergo apoptosis and become cornified squames (see Fig. 1A and diagram). AP-2 is highly expressed in the basal layer (Fig. 1B) , with most of the immunofluorescent signal coming from AP-2␣ (Mitchell et al., 1991 ; and see Fig. 1EЈ ) although some contribution from AP-2␤ and AP-2␥ cannot be excluded (see Materials and Methods). In contrast, K10 appears only in the suprabasal layers (Fig. 1C) . C/EBP␣ is found in the upper suprabasal layers (Fig. 1D ), whereas C/EBP␤ is found in low amounts in the basal layer and increases at the transition zone between basal and suprabasal layers (Fig. 1E ). C/EBP␤ and AP-2 are both expressed in the basal layer, but levels of these two factors change in a reciprocal manner; i.e., as cells migrate upward into the cornified epithelium, C/EBP␤ increases and AP-2 decreases (Figs. 1E and 1EЈ ).
Immunocolocalization studies can establish putative relationships between the expression of transcription factors and potential target genes such as k10. Thus, AP-2 colocalizes with C/EBP␤ in the basal layer (Figs. 1E and 1EЈ) , where K10 expression is absent. At the basal/suprabasal boundary, K10 expression begins; cells expressing K10 display an increase in C/EBP␤ relative to the basal layer (Figs. 1F, 1FЈ , and 1FЉ). In the high suprabasal (granular) layers, where expression of C/EBP␤ begins to decline, K10 expression colocalizes with C/EBP␣ (cf. Figs. 1D and 1F ).
The Promoter of the k10 Gene Contains Three Functional C/EBP Binding Sites
To determine whether C/EBPs might be involved in the upregulation of k10 expression during keratinocyte differ-entiation, a k10 promoter fragment was isolated for use in binding and transactivation studies in BALB/MK cells, an immortalized keratinocyte line (Weissman and Aaronson, 1983 ) that reproduces many of the differentiation-related changes that occur in the epidermis, including the sequential upregulation of C/EBP␤ and C/EBP␣ (Maytin and Habener, 1998) . The BALB/MK cells, exposed to high-calcium (differentiation-promoting) medium, respond with an increase in K10 expression within 24 h, measurable at the protein ( Fig. 2A) and mRNA (Fig. 2B ) levels. These results agree with earlier findings in which K10 increases in primary murine keratinocytes at 1-2 days of differentiation (Yuspa et al., 1989) .
The cloned segment of the 5Ј flanking region of mouse k10 revealed several features (Fig. 3A) . Nucleotide similarities were found with the human (Rieger and Franke, 1988) and bovine (Rieger et al., 1985) k10 promoters. An identity of 95-100% nucleotides is present in the first 170 bp, a sequence containing three C/EBP binding sites (designated A, B, and C). All three sites (Site B oriented in the reverse direction) closely resemble the consensus binding motif for C/EBPs (Fig. 3A, bottom) . To determine whether these sites bind C/EBPs, DNase I protection analyses of the k10 promoter were performed (Fig. 3B ). Recombinant C/EBP␤ protected a region extending from Ϫ140 to Ϫ176 bp (Fig.  3B) . A hypersensitive region was found within this footprint, between Sites A and B (Fig. 3B, asterisk) . Site C corresponded to a location that showed weak protection from DNase I, but was flanked by two strong hypersensitive sites consistent with a possible C/EBP␤-induced conforma- tional change in the DNA (Fig. 3B, upper two asterisks) . The individual DNA sequence motifs were tested in gel-shift assays for their ability to bind C/EBPs (Fig. 3C) .
32 P-labeled oligonucleotides, corresponding to each of the three motifs, bound recombinant C/EBP␤ in a C/EBP-specific manner, as demonstrated via competition with a high-affinity C/EBPbinding oligonucleotide and via supershift studies with antisera against C/EBP␤ (Fig. 3C) . Oligonucleotides with mutations in each of the sites (Mut A, Mut B, or Mut C) failed to compete for C/EBP␤ binding and failed to bind C/EBP␤ when used as probes (Fig. 3C) . The affinity of binding to C/EBP␤ differed for each of the sites, with the affinity at Site A being 5-to 10-fold higher than for sites B and C, based upon differential film exposure times (data not shown). However, the affinities of the sites measured in isolation (Fig. 3C) do not address the issue of cooperative binding effects, observed when the sites lie adjacent to one another in native k10 DNA (see below).
C/EBP␤ Is Present in Keratinocyte Nuclear Extracts and Binds to the k10 Promoter in a Differentiation-Specific Manner
To show that C/EBPs are present within nuclei and bind to the k10 promoter in a differentiation-specific manner, proteins were extracted from the nuclei of BALB/MK cells at various times during calcium-induced differentiation and analyzed for C/EBP-binding activity via gel-shift analysis. Nuclear extracts were mixed with a 44-bp probe containing Sites A and B from the k10 promoter. Two specific complexes which increased in intensity over the first 3 days of differentiation, and then decreased by 7 days, were observed (Fig. 3D) . The composition of these complexes was examined via immunosupershift and oligonucleotide competition experiments (Fig. 3D) . Specific complexes were disrupted by antisera against C/EBP␤ (lane 6), but not by antisera to C/EBP␣ nor CHOP. DNA competition with the M6 oligonucleotide, a high-affinity C/EBP-binding site (Brasier et al., 1990) , selectively abolished the specific complexes (lanes 9 and 10), whereas competition with the unlabeled k10 probe itself competed both the specific and the nonspecific complexes (lanes 11 and 12). These results implicate C/EBP␤ as a predominant factor responsible for differentiation-dependent binding activity at the C/EBPbinding sites within the k10 promoter during the differentiation of BALB/MK cells.
C/EBP␤ Introduced into Keratinocytes Activates the k10 Promoter through a Mechanism That Is C/EBP-Specific and DNA Binding Site-Specific
To test whether C/EBPs can regulate k10 transcription in vivo, a reporter plasmid containing the 245-bp wild-type k10 promoter fused to the luciferase reporter gene (pWtK10Luc) was cotransfected into BALB/MK cells with expression plasmids for C/EBP␣, C/EBP␤, or CHOP (Fig. 4) . Expression of both C/EBP␣ and C/EBP␤ activated pWtK10Luc by 6-to 12-fold relative to the empty expression vector, pCDNA (Fig. 4A ). C/EBP␣ was more effective than C/EBP␤ in activating the k10 reporter. CHOP, as expected from its inability to bind DNA (Ron and Habener, 1992) , failed to activate the k10 reporter. The empty luciferase reporter vector alone, pOLuc, was not affected by any of the expression constructs, confirming that transactivation effects observed were attributable to k10 promoter sequences.
Additional transfection/transactivation experiments were performed to test the specificity of interactions between k10 and C/EBP. Cotransfection of full-length 32-kDa C/EBP␤ (LAP) and pWtK10Luc resulted in transactivation of the k10 promoter (Fig. 5B, left side) . A fivefold excess of the 20-kDa inhibitory form of C/EBP␤ (LIP), introduced into the cells along with LAP, attenuated the transactivation of k10. Similarly, overexpression of the dominant-negative inhibitor, CHOP, also inhibited transactivation. These effects depended on the presence of intact C/EBP-recognition sites in DNA, because a k10 promoter construct (pMutABC) containing RT-PCR using primers to a region at the 3Ј end of the K10 mRNA; ethidium-stained agarose gels are shown. (Bottom) Southern blots from the same gels, probed with a 32 P-labeled K10 probe. Controls, PCRs were run with a plasmid containing a K10 cDNA insert (pK10) and with cDNA prepared from mouse epidermal RNA (skin). (C) RT-PCR products from the same RNA samples used in (B), using primers specific for mouse actin. pActin, a control from PCR amplification of a plasmid containing mouse actin sequences. point mutations at Sites A, B, and C failed to respond to C/EBP␤, either in the presence or in the absence of excess inhibitory proteins (Fig. 5B, right) .
Full Activation of the k10 Promoter by C/EBP␤ Requires Three Intact C/EBP-Binding Sites within the Promoter
The role of each C/EBP-binding site in the k10 promoter was examined by creating point mutations within Sites A, B, and C (Figs. 4C-4E ). Each mutation abolished binding of C/EBP␤ at the individual sites; see Fig. 3C . Mutations were introduced into the k10 promoter either individually or together in all combinations, to yield a panel of mutant k10 transcriptional reporters (Fig. 4C ). These reporters were tested in cotransfection experiments with a C/EBP␤ expression vector (Fig. 4D) . The effects of these mutations upon transcriptional activity proved to be complex, with loss of any one of the sites leading to derepression of basal transcription and a concomitant loss in relative C/EBP regulatability. The latter point is best seen in Fig. 4E , in which the mutants are displayed in decreasing order of ability to respond to C/EBP␤. Thus, in comparison to the fourfold induction of the wild-type k10-luciferase reporter after C/EBP␤, mutation of Site A alone caused only a 50% reduction in C/EBP␤-stimulated activity of the k10 promoter. Elimination of either Site B or Site C caused smaller reductions in k10 activity. Double mutants confirmed the relative importance of Site A; constructs with a mutation in B and A or C and A, but not B and C, showed significant decreases in k10 activation by C/EBP␤. Importantly, however, only the triple mutation (Mut ABC) showed 100% loss of C/EBP␤-inducibility. Therefore, despite the higher affinity of Site A relative to Sites B or C when tested in isolation (Fig. 3C) , all three sites appear to be important in the native promoter, i.e., all must be intact to achieve full activation of the k10 promoter in response to C/EBP␤.
Targeted Disruption of the c/ebp␤ Gene Results in Ectopic Increases in Expression of C/EBP␣ and K10 in the Basal Layer of the Epidermis
Having established a role for C/EBP␤ in the regulation of the k10 promoter in vitro, we investigated its role in the skin in vivo. A targeted disruption of the c/ebp␤ gene in mice, which led to the development of lymphocyte abnormalities in aged mice, was described previously; no phenotypic changes were reported in the skin (Screpanti et al., 1995) . When these mice were backcrossed into a FVB/n background, a skin phenotype appeared (Fig. 5) . The c/ ebp␤   FIG. 3 . The mouse k10 promoter contains three C/EBP binding motifs which specifically bind C/EBPs, including C/EBP␤ found in keratinocyte nuclear extracts. (A) Comparison of the murine k10 proximal promoter region with the corresponding regions of human and bovine k10 genes; locations of C/EBP-binding motifs. Nucleotides conserved between at least two of the three species are shaded. The TATA-binding site, the transcription initiation site (TRX) and the translation start site (TRL) are boxed. Sites A, B, and C, representing candidate sites for binding of C/EBPs, are delineated by boxes and are also shown at the lower right beneath the consensus motif for C/EBP binding (Osada et al., 1996) . The sequence labeled "mK10 in 1985" denotes the 5Ј end of the published sequence of the murine k10 gene (Krieg et al., 1985) ; bases that differ from our sequence are shown, while identical bases are indicated by asterisks. (B) DNase I protection analysis of the K10 promoter. A 245-bp fragment of the murine k10 promoter was labeled with 32 P at the 5Ј terminus and incubated with increasing amounts (0, 50, 100, 200, 400, and 800 ng) of a recombinant 20-kDa isoform (LIP) of C/EBP␤ and then separated on an acrylamide gel and exposed to film. Footprinted regions (vertical arrows, on right) encompass the C/EBP␤-binding sites predicted from A (vertical boxes). Hypersensitive sites are indicated by asterisks. Nucleotide locations, derived from the sequencing lane (G-ladder), are given on the left. (C) Gel-shift analyses demonstrating the affinity and specificity of binding for each of three sites (A, B, and C) in the K10 promoter to a recombinant C/EBP␤. In the three gels on the right, three different 32 P-labeled 26-bp oligonucleotides derived from the wild-type k10 promoter sequence (wildtype Site A, B, or C; see A and Materials and Methods) or 26-bp oligonucleotides with mutations at sites A, B, or C (mA, mB, or mC; also see Fig. 4C and Materials and Methods) were incubated with 1 l of a gst-C/EBP␤ bacterial lysate or with the probe alone. In the gel on the left, a standard high-affinity C/EBP-binding site (Standard; the M6 mutant from the angiotensinogen gene) (Brasier et al., 1990) served as the probe. Locations of DNA-protein complexes (C/EBP␤ϩDNA) and free probe are indicated. In all gels, numbered lanes indicate the following successive additions (also see labeling above the gels): (1) probe alone, (2) gst-C/EBP␤ protein, (3) 100-fold excess of unlabeled C/EBP␤ standard (S) oligonucleotide, (4) 100-fold excess of unlabeled probe itself (A, B, or C), (5) 100-fold excess of unlabeled mutant oligonucleotide (mA, mB, or mC), (6) antibody against C/EBP␤. In lane (7), gst-C/EBP␤ protein was incubated with a 32 P-labeled mutant probe (mA, mB, or mC) to demonstrate absence of binding at the mutated sites. Film exposure time was 40 h for the Site A probes, 7 days for the Site B and Site C probes. (D) Characterization of native C/EBP-binding activity in differentiating BALB/MK cells. Time course: Nuclear extracts, 1 l, from cells exposed to 0.12 mM calcium for 0, 3, or 7 days were mixed with a radiolabeled 40-bp oligonucleotide (K10 probe) containing Sites A and B from the K10 promoter (see Materials and Methods). Changes in two specific complexes (SC) and a nonspecific complex (NS) were observed. In the subsequent experiments, 1 l of 3-day nuclear extract was used in all lanes. Supershift analysis with antisera: Addition of either 1 l of anti-C/EBP␣ antisera (lane 5), or anti-CHOP antisera (lane 7), had no effect, but anti-C/EBP␤ antisera (lane 6) perturbed the specific complexes and formed supershifted complexes instead. Oligonucleotide competition: Addition of a 10-fold (lane 9) or 100-fold (lane 10) excess of unlabeled standard oligonucleotide (M6) eliminated binding only of the specific C/EBP-containing complexes. The K10 probe itself (K10, lanes 11 and 12) competed both the C/EBP-specific and the nonspecific bands, as expected. Supershift (SS) controls: Positive controls to show that the antisera are capable of supershifting recombinant gst-C/EBP␣ (lanes 13 and 14) or C/EBP␤ (lanes 15 and 16) . The M6 probe (Standard) was described in C. null mice were slightly smaller than controls and manifested a scruffy appearance of their coats (Fig. 5, top left) . The phenotypic changes in the fur allowed identification of homozygous animals before confirmation by genotyping. The histomorphology of hematoxylin-and eosin-stained skin in the c/ebp␤ null-mice appeared similar to that of controls; no obvious changes in the epidermis and dermis, nor in the size and number of hair follicles, were seen (Figs.
5A and 5AЈ). However, substantial (ϳ50%) thinning of the subcutaneous fat layer was observed (see Fig. 5AЈ and figure legend), consistent with the decreases in interscapular and epididymal adipose tissue previously reported in c/ebp␤ null mice (Tanaka et al., 1995) .
Closer examination of skin sections using a panel of antisera directed against transcription factors and keratins revealed major differences between c/ebp␤ null and control , and harvested at 48 h for luciferase assay. Raw data were pooled from three experiments, each condition in duplicate or triplicate. Error bars represent the means Ϯ SEM. For each K10 mutant, the relative ratio (fold increase) due to addition of C/EBP␤ is given above the bar. (E) Induction ratios for the wild-type and mutant k10-luciferase constructs, displayed in order of decreasing ability to respond to C/EBP␤. Error bars represent means Ϯ SEM. Asterisks, significant difference from the wild-type construct, WtK10Luc, by one-sided Student t test (*P Ͻ 0.01; **P Ͻ 0.001). mice (Fig. 5) . C/EBP␤ protein was absent in the epidermis of c/ebp␤ null mice (Figs. 5B and 5BЈ ). Although CHOP expression remained unchanged (Figs. 5C and 5CЈ) , a marked increase in the distribution of C/EBP␣ expression was observed within the epidermal layers (Figs. 5D and  5DЈ ). Compared to the normal pattern of C/EBP␣ expression (in the high suprabasal layers), C/EBP␣ in c/ebp␤ null mice extended downward to include all of the cells in the suprabasal and basal layers. C/EBP␣ expression was increased in both concentration (fluorescent intensity) and geographic area (Fig. 5DЈ) . These changes in expression of C/EBP␣ were significant when the skins of multiple animals were studied by computer-assisted image analysis (Table 1) . Notably, in the epidermis of c/ebp␤ null mice, the expression of K10 was also markedly increased (Figs. 5E and 5EЈ). The normal suprabasal pattern of K10 now expanded downward into the basal layer (Fig. 5EЈ) . Upregulation of K10 appeared to be specific, because the expression levels of another epidermal keratin, K14, remained unchanged (Figs. 5F and 5FЈ).
AP-2 Resides in a Pathway between C/EBP␤ and C/EBP␣, Linking the Increase of C/EBP␣ to the Loss of C/EBP␤ in the Epidermis of c/ebp␤ Null Mice
As an explanation for the increase in C/EBP␣ expression in c/ebp␤ null skin (e.g., active stimulation versus removal of repression), we considered repression of c/ebp␣ gene expression by AP-2. Such an explanation would have to include a role for C/EBP␤ in the maintenance of AP-2 expression, in order to explain derepression of C/EBP␣ in the skin of c/ebp␤ null mice. Two experiments were performed, the results of which support such a role. First, immunostaining demonstrated a near complete disappearance of AP-2 in the epidermis of c/ebp␤ null mice, consistent with the notion that C/EBP␤ is essential for AP-2 expression (Figs. 5G and 5GЈ) . Second, an examination of regulatory sequences upstream of the AP-2␣ gene (Meier et al., 1995) revealed several potential C/EBP-binding site motifs. Two of these motifs, located at nucleotide positions 315 and 365 (GenBank Accession No. U17289), were tested for their activity as C/EBP␤-responsive enhancers of transcription. An 87-bp sequence of the AP-2 promoter containing these two motifs was linked to a transcriptional reporter comprising the K10 minimal promoter fused to the luciferase gene (see Materials and Methods). When cotransfected into keratinocytes in the absence or presence of an expression plasmid for C/EBP␤, the AP-2 promoter was activated in a C/EBP-dependent manner (Fig. 6) . Disruption of the binding motifs by selective mutation completely abolished C/EBP␤-inducibility of the AP-2 promoter (Fig. 6 ).
ap-2␣ Nullizygous Mice Reproduce the Skin Phenotype of c/ebp␤ Null Mice, with Increased Epidermal C/EBP␣ and K10
To determine whether c/ebp␤ and ap-2␣ may lie in a pathway upstream of c/ebp␣ and k10, epidermis from mice lacking the ap-2␣ gene was examined (Schorle et al., 1996) . Experiments were limited to late-stage fetal skin, since ap-2␣ null mice die perinatally with severe cranial and abdominal wall defects (Schorle et al., 1996) . However, these mice develop intact skin over the upper thoracic region (Zhang et al., 1996) . Frozen sections from 17.5-to 18.5-day embryos were tested using the panel of antisera shown in Fig. 7 . As with c/ebp␤ null mice, the ap-2␣ null mice showed an overall increase in C/EBP␣ staining intensity (Figs. 7B and 7BЈ and Table 2 ) and a marked increase in C/EBP␣ expressed ectopically in basal cell nuclei (Figs. 7C  and 7CЈ ). K10 expression was increased in the suprabasal layers (Figs. 7E and 7EЈ and Table 2 ), although no expansion into the basal layer was noted in this case. No changes were seen in the hair follicles. The levels of expression of C/EBP␤ (Figs. 7D and 7DЈ) , K14 (Figs. 7F and 7FЈ) , and CHOP (data not shown) were unchanged.
DISCUSSION
An important goal in epidermal biology is to identify differentiation-specific transcription factors that determine the expression of tissue-specific target genes during kera- a Histologic specimens (5-m frozen sections) from the skin of paired littermates, laid adjacent to one another on microscope slides, were immunostained with primary antisera to the proteins indicated, followed by Cy3-conjugated secondary antisera, and fluorescence intensity was analyzed as described under Materials and Methods. Values shown represent the means Ϯ SD (n ϭ 6 fields/animal) of integrated fluorescence intensity per unit length of epidermis. Unit length was used for normalization rather than unit area, since epidermal thickness can vary considerably. Statistical comparison by the Student t test (P value) is shown for each pair of animals.
b No values are listed for C/EBP␤ because quantitation was not required to demonstrate the all-or-none difference between strong C/EBP␤-specific signals in controls versus the complete absence of signal in the c/ebp␤ Ϫ/Ϫ mice.
* P Ͻ 0.01. ** P Ͻ 0.005. *** P Ͻ 0.0005. tinocyte differentiation (reviewed in Fuchs, 1993) . Here we show that C/EBP and AP-2 transcription factors together regulate the transcriptional activity of the keratin k10 gene in the epidermis. C/EBPs act directly upon the k10 promoter. Although C/EBP␣ and C/EBP␤ can both activate the k10 gene, they are differentially expressed in the stratified epidermis. C/EBP␤ acts early and C/EBP␣ acts later during upward migration and differentiation of keratinocytes. AP-2 influences k10 transcription indirectly as a repressor of C/EBP␣ expression in the basal layer of the epidermis, where C/EBP␤ and AP-2 are both expressed. In the high suprabasal layers, AP-2 expression is extinguished and C/EBP␤ expression is superceded by expression of C/EBP␣. A novel aspect of the findings is that c/ebp␣, c/ebp␤, and ap-2␣ genes are functionally linked in a regulatory network that ultimately determines the expression of the k10 gene in the skin in vivo.
C/EBPs Directly Regulate k10 Gene Transcription
Although the suprabasal expression pattern of keratin k10 in the epidermis has been well characterized (Roop et al., 1988; Yuspa et al., 1989) , the regulation of the k10 promoter has not been examined in detail. We identified a cluster of three C/EBP-binding sites within the proximal k10 promoter via footprint and gel-shift analysis. All three sites were shown by site-directed mutagenesis studies to be essential for C/EBP responsiveness of the k10 promoter (Figs. 3 and 4) . The presence of these sites appears to maintain the k10 promoter in a relatively suppressed state at baseline, since mutation of any one of the three sites increases basal promoter activity in keratinocytes (Fig. 4D) . Whether this reflects a physical interaction between the sites through bending of the chromatin (e.g., hairpin formation in the presence of C/EBPs and/or other binding proteins), as shown for the case of multiple CREB-responsive elements (Spiro et al., 1995) , is an interesting hypothesis for future study. For purposes here, characterization of the C/EBP-responsive sites was essential to confirm that the k10 promoter can be regulated by C/EBPs at the transcriptional level.
Multiple C/EBP-responsive motifs have been demonstrated experimentally in only a few other genes to date, including keratin K6 (Blumenberg et al., 1998) and ␣-1 acid glycoprotein (Lee et al., 1993) . For the k10 promoter, such redundancy may preserve transcriptional expression of this vital intermediate filament gene. The disease epidermolytic hyperkeratosis illustrates the importance of proper k10 expression in cutaneous biology. K10 normally assembles into cytoskeletal filaments as a heterodimer with its specific partner, keratin K1; together, K1 and K10 constitute ϳ85% of the protein in fully differentiated keratinocytes (Cheng et al., 1992) . Perturbation of K1:K10 filaments via dominant-negative mutations in K10, either introduced experimentally into transgenic mice or naturally occurring in the heritable disease epidermolytic hyperkeratosis (Cheng et al., 1992; Rothnagel et al., 1992; Syder et al., 1994) , leads to epidermal cytolysis and blistering, with severe clinical consequences.
AP-2 Acts Indirectly upon k10 Expression via Activation or Repression of the c/ebp␣, c/ebp␤, and ap-2␣ Gene Promoters
To determine how C/EBP␣ and C/EBP␤ regulate k10 expression in the skin in vivo, we examined the skin of mice lacking c/ebp␤. In the c/ebp␤ null animals, the k10 phenotype of increased expression was initially difficult to explain. However, it was noted that C/EBP␣ transactivates the k10 promoter (Fig. 4A) . In the c/ebp␤ null mice, loss of C/EBP␤ is compensated for by an increase in epidermal C/EBP␣. It is reasonable to propose that C/EBP␣ activates transcription of the k10 gene in c/ebp␤ null mice because C/EBP␣ and K10 are both expressed ectopically in cells of the basal layer, a place where neither gene is normally expressed.
Why is C/EBP␣ upregulated in the skin of c/ebp␤ null mice? Among several possible mechanisms, a release from transcriptional repression was considered. Analogous to the FIG. 6. C/EBP␤-responsive enhancer elements are found in the upstream regulatory region (exon 1a) of the ap-2␣ gene. Luciferase reporter constructs were constructed by placing an 87-bp region of the ap-2␣ promoter containing two putative C/EBP-enhancers at Ϫ710 and Ϫ760 bp (pWtAP2Luc) in front of the luciferase gene driven by a minimal promoter (LUC); see Materials and Methods. In a mutant version of the construct, both AP-2 enhancers were disrupted by site-directed mutagenesis (pMutAP2Luc; mutant bases in lowercase italic). Each of these constructs, or the empty reporter (pOLuc), was cotransfected with C/EBP␤-expression plasmid (hatched bars) or empty pCDNA (open bars) into BALB/MK cells, and the cells were harvested at 48 h for luciferase assay. Data were pooled from three experiments, each performed in triplicate, and normalized using the baseline (empty vector) values; error bars represents the means Ϯ SEM.
role of AP-2 as a repressor of the c/ebp␣ promoter in mitotic preadipocytes (Jiang et al., 1998) , we hypothesized that AP-2 may be a repressor of C/EBP␣ in the basal epidermis. This hypothesis is supported by our findings that in the skin of ap-2 null animals, expression of C/EBP␣ is increased (Fig. 7) . Also, because AP-2 expression is lost in the epidermis of c/ebp␤ null mice, loss of AP-2-mediated repression can explain the high C/EBP␣ levels seen in those animals (Fig. 5) . Why is AP-2 expression lost in c/ebp␤ null mice? At least part of the mechanism may be transcriptional, since we have shown that the ap-2␣ gene promoter contains at least two C/EBP-responsive enhancer elements (Fig. 6) . Collectively, the above observations suggest a model in which c/ebp␤, ap-2␣, and c/ebp␣ genes are linked in a regulatory network (Fig. 8) . Within a given cell (e.g., a keratinocyte in the basal layer), C/EBP␤ activates or maintains transcription of the ap-2␣ promoter (Fig. 8A) . AP-2, in turn, represses C/EBP␣ expression. In c/ebp␤ null mice (Fig.  8B) , the elimination of AP-2 expression unmasks a C/EBPbinding site in the C/EBP␣ promoter (Tang et al., 1997) , allowing positive autoregulation of C/EBP␣ and subsequent upregulation of k10. Elimination of ap-2␣ by gene targeting yields a skin phenotype similar to that in Fig. 8B , with the a Paired histologic specimens were immunostained with primary antisera to either C/EBP␣ or K10, followed by secondary antisera conjugated to Cy3, and were then quantitated by digital image processing as described under Materials and Methods and the legend to Table 1 . Values (means Ϯ SD, n ϭ 6 microscopic fields/animal) represent integrated fluorescence intensity per unit length of epidermis. The Student t test results (P values) are shown for each pair of animals.
* P Ͻ 0.001. ** P Ͻ 0.0005. exception that C/EBP␤ remains unaltered, since it lies upstream of ap-2␣.
The geographic distribution of C/EBP␣, C/EBP␤, and AP-2 within the various epidermal layers plays a role in k10 expression in vivo, as summarized in Fig. 8C . Normally, C/EBP␤ is present in low amounts in the basal cells, then undergoes a surge of expression as the cells enter the suprabasal layers. C/EBP␣ is normally repressed in the basal layers by the presence of AP-2. Once AP-2 expression is lost, in either the c/ebp␤ or the ap-2␣ knockout models, C/EBP␣ expression is activated in the lower epidermis, with qualitative increases in the basal layer (Figs. 7C and 7CЈ) and quantitative increases in the low suprabasal layers (Tables 1 and 2 ). Increased C/EBP␣ expression leads to augmented k10 expression at the locations noted (Fig. 8C) . While we have shown that either C/EBP␣ or C/EBP␤ can contribute to k10 expression (Fig. 4A) , C/EBPs are clearly not the only factors involved. For example, k10 expression is normally off in the basal layer, even in the presence of low amounts of C/EBP␤. Therefore, additional unknown factors (designated "Z" in Fig. 8 ) must play a role in the activation of k10 at the basal/suprabasal transition.
Potential for Additional Regulatory Interactions
Our data raise several additional questions. For example, why does the expression of keratin K14 remain unaltered in the ap-2␣ null and the c/ebp␤ null mice, despite reports that AP-2 is intimately involved in k14 transcription (Byrne et al., 1994; Leask et al., 1991) ? It is possible that multiple AP-2 family genes are expressed in the skin. Epidermal expression of AP-2␤ (Moser et al., 1997) and of AP-2␥ (Buehner et al., 1998; Oulad-Abdelghani et al., 1996) has been reported in mouse skin at the mRNA level. In our work, expression of several AP-2 family proteins in murine epidermis is suggested by the persistence of faint immunostaining of the basal layer of the epidermis in ap-2␣ null mice using the sc-184 antibody from Santa Cruz, Inc. (data not shown). The sc-184 antibody is not specific for AP-2␣, since it also detects AP-2␤ and AP-2␥ (albeit to a lesser extent) when tested against in vitro-translated proteins on Western blots; see Materials and Methods. Thus, in mice lacking AP-2␣, the presence of AP-2␤ and AP-2␥ may be sufficient to maintain k14 gene expression. In contrast, AP-2␤ and AP-2␥ (assuming they are present) appear to be much less effective than AP-2␣ in repressing the c/ebp␣ gene, since C/EBP␣ is strongly upregulated in the epidermis of ap-2␣ null mice.
Another question is the possible involvement of alternative isoforms of c/ebp␣, c/ebp␤, and ap-2␣ in the regulation of k10. For example, LIP (a C/EBP␤ isoform) or the 30-kDa isoform of C/EBP␣ might counteract stimulatory effects of activator C/EBP isoforms. We have demonstrated that the long and short protein isoforms of both C/EBP␣ and C/EBP␤ are expressed in the epidermis (Maytin and Habener, 1998) . A major role for these short isoforms seems unlikely, however, because the amount of the short isoforms relative to the full-length proteins is small (Ͻ20%) and because no significant changes in the ratios of LIP to full-length C/EBP␤ or of C/EBP␣-30 kDa to full-length C/EBP␣ were observed (data not shown). Likewise, no major changes in levels of CHOP were observed in this study. However, because CHOP (a dominant-negative repressor of C/EBPs) is expressed in the epidermis along a gradient similar to that of C/EBP␤ (Maytin and Habener, 1998) , we cannot exclude a counterregulatory role for CHOP that might be demonstrable in a different experimental context. In the case of AP-2, a role for multiple isoforms must also be considered. Four AP-2 isoforms, produced by alternative RNA splicing, are expressed in murine skin (Meier et al., 1995) . In particular, a splicing variant which can form heterodimers but lacks the N-terminal transactivation domain could function as a dominant-negative inhibitor (Meier et al., 1995) . The large number of isoforms, each with a potential to participate in autoregulation and cross-regulation among the C/EBP-family and AP-2 family genes, adds to the potential complexity of k10 regulation.
